PDL BioPharma, Inc. (PDLI)

S&P 500: 1,056.89
Change: -3.85%

A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.

Recs

Avatar odmonk (72.69) Submitted: 2/22/08 5:25 PM : Start Price: $11.09 PDLI Score: -2.00

I expect this to drift a bit but underperform until at least fall. Longterm prospects are not that bad, though.

Featured Broker Partners